UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-KSB
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 1, 1997
MEDICAL STERILIZATION, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 2-85008-NY 11-2621408
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer or
incorporation) File Number) Identification No.)
225 Underhill Boulevard, Syosset, New York 11791
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (516) 496-8822
Item 4. Changes in Registrant's Certifying Accountant
(a)(1)(i) The Registrant's former accountant, Coopers & Lybrand L.L.P., by
letter dated October 1, 1997 advised the Registrant that the client-auditor
relationship between the Registrant and Coopers & Lybrand L.L.P. has ceased due
to their resignation.
(ii) The report of Coopers & Lybrand L.L.P. on the financial
statements for either the year ending December 31, 1995 or December 31, 1996 did
not contain an adverse opinion or disclaimer of opinion, or was modified as to
uncertainty, audit scope, or accounting principles.
(iii) The decision to change accountants was not recommended or
approved by the Board of Directors or an Audit Committee of the Board of
Directors.
(iv) There are no disagreements with Coopers & Lybrand L.L.P.,
whether or not resolved, on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which, if not
resolved to the satisfaction of Coopers & Lybrand L.L.P., would have caused it
to make reference to the subject matter of the disagreement in connection with
its report.
<PAGE>
(3) The Registrant has provided Coopers & Lybrand L.L.P. with a copy of
the disclosures it is making in response to this item and has requested Coopers
& Lybrand L.L.P. to furnish a letter addressed to the Commission stating whether
it agrees with the statements made by the Registrant and, if not, stating the
respects in which it does not agree. The letter from Coopers & Lybrand L.L.P.
has been filed as an exhibit to the report containing this disclosure.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) not applicable
(b) not applicable
(c) Exhibits
16 Letter re: Change of Certifying Accountant
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be filed on its behalf by the
undersigned hereunto duly authorized.
Date: October 1, 1997
MEDICAL STERILIZATION, INC.
By: /s/ D. Michael Deignan
----------------------------------------------
Name: D. Michael Deignan
Title: President, Chief Executive Officer and
Principal Financial Officer
3
[LETTERHEAD OF COOPERS & LYBRAND L.L.P.]
October 1, 1997
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Gentlemen:
We have read the statements made by Medical Sterilization, Inc. (copy attached),
which we understand will be filed with the Commission pursuant to Item 4 of Form
8-K, as part of the Company's Form 8-K report for the month of October 1997. We
agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ Coopers & Lybrand L.L.P.
